SECURITIES AND EXCHANGE COMMISSION

                           Washington, D.C.  20549

                                  FORM 8-K

                               CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities and Exchange Act


                              November 17, 2004
                              -----------------
                               Date of Report
                     (Date of earliest event reported)


                             SANGUINE CORPORATION
                             --------------------
           (Exact Name of Registrant as Specified in its Charter)

      Nevada                    0-24480                   95-4347608
      ------                    -------                   ----------
  (State of other        (Commission File No.)      (IRS Employer I.D. No.)
    Jurisdiction)

                          101 East Green Street, #11
                          Pasadena, California 91105
                          --------------------------
                  (Address of Principal Executive Offices)

                               (626) 405-0079
                               --------------
                       (Registrant's Telephone Number)

                                    N/A
                                    ---
        (Former Name or Former Address if changed Since Last Report)



          Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the Registrant under any of
the following provisions (see general instruction A.2. below):

     [ ] Written communications pursuant to Rule 425 under the Securities Act
         (17 CFR 230.425)

     [ ] Soliciting material pursuant to Rule 14-a-12 under the Exchange Act
         (17 CFR 240.14a-12)

     [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
         Exchange Act (17 CFR 240.14d-2(b))

     [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
         Exchange Act (17 CFR 240.13e-4(c))


Item 7.01   Regulation F D Disclosure.
            --------------------------

          See the Press Release attached hereto and incorporated herein by
reference as Exhibit 99.1.  See Item 9.01.

Item 9.01   Financial Statements and Exhibits.
            ----------------------------------

         (c) Exhibits.

Description of Exhibit                          Exhibit Number
----------------------                          --------------

Press Release dated November 17, 2004                99.1

                           SIGNATURES

          Pursuant to the requirements of the Securities and Exchange Act of
1934, the Registrant has duly caused this Report to be signed on its behalf by
the undersigned hereunto duly authorized.

                                                   SANGUINE CORPORATION

Dated: 11/17/04                                    /s/ Thomas C. Drees
       --------                                    --------------------------
                                                   Thomas C. Drees, Ph.D., MBA
                                                   President and
                                                   Director